Yahoo · Sep 2, 2026
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
Sector ETF report for IHI
IH
AMEX · IHI
iShares U.S. Medical Devices ETF
Financial Services · Asset Management
$51.70
Up+$0.07 (+0.14%)
Updated Sep 19, 2026, 1:28 AM
SID Score
4.4/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 4.35B
- P/E ratio
- —
- Dividend yield
- 0.50%
- 52-week range
- $47.37 – $57.44
- Volume
- 2.16M
- Avg. volume
- 1.22M
Price performance
IHI price history
1M range · 19 trading sessions · Daily adjusted prices
IHI closed at $51.70 after 19 trading sessions, down 7.96% for the selected period.
- Last close
- $51.70
- Period change
- -7.96%
- Period low
- $50.88
- Period high
- $56.17
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $52.11 | $52.11 | $51.36 | $51.70 | 2.16M |
| Sep 16, 2026 | $51.715 | $52.43 | $51.64 | $51.90 | 1.73M |
| Sep 15, 2026 | $51.51 | $52.02 | $51.21 | $51.78 | 9.7M |
| Sep 14, 2026 | $51.59 | $52.05 | $51.555 | $51.86 | 2.51M |
| Sep 11, 2026 | $51.23 | $51.50 | $50.49 | $50.88 | 1.78M |
| Sep 10, 2026 | $51.06 | $51.61 | $50.724 | $50.90 | 2.09M |
| Sep 9, 2026 | $51.51 | $52.06 | $51.32 | $51.48 | 2.22M |
| Sep 8, 2026 | $53.10 | $53.135 | $51.5595 | $51.74 | 3.2M |
| Sep 4, 2026 | $53.315 | $53.87 | $53.30 | $53.63 | 1.51M |
| Sep 3, 2026 | $54.76 | $55.14 | $53.495 | $53.91 | 2.38M |
| Sep 2, 2026 | $54.34 | $55.505 | $54.27 | $54.42 | 2.22M |
| Sep 1, 2026 | $55.38 | $55.77 | $54.155 | $54.29 | 1.95M |
| Aug 31, 2026 | $54.73 | $55.04 | $54.385 | $54.97 | 1.88M |
| Aug 28, 2026 | $54.67 | $55.285 | $54.67 | $55.19 | 1.79M |
| Aug 27, 2026 | $55.00 | $55.26 | $54.605 | $54.62 | 4.19M |
| Aug 26, 2026 | $55.29 | $55.75 | $55.19 | $55.39 | 1.64M |
| Aug 25, 2026 | $55.71 | $55.88 | $55.28 | $55.71 | 1.48M |
| Aug 24, 2026 | $56.175 | $56.46 | $55.775 | $55.88 | 2.75M |
| Aug 21, 2026 | $55.48 | $56.27 | $55.12 | $56.17 | 1.53M |
Latest IHI news
The latest Smart Investors Daily articles mentioning IHI.
Stock researchCompany · Overview
IHI research
Overview
Company profile and research snapshot.
Company profile
The fund will invest at least 80% of its assets in the component securities of the index and in investments that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the index, but which BFA believes will help the fund track the index. The fund is non-diversified.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
SeekingAlpha · Aug 29, 2026
IHI: Limited Upside With Unfavorable Risk-Reward
IHI's top three holdingsâABT, ISRG, and SYKâcomprise nearly 43% of the portfolio, amplifying downside risk if growth falters. Read why IHI ETF is a Sell.
SeekingAlpha · Jun 14, 2026
IHI: Pressured Consumers, Unclear Healthcare Policy, Weak Price Action
Hold iShares US Medical Devices ETF (IHI) after a 20% YTD drop: fair valuation but bearish technicals, concentration risks and low yieldâread now.
SeekingAlpha · Mar 4, 2026
DexCom: Gaining Favor, With Useful Tailwinds To Support It Even Further
Dexcom (DXCM) outlook: CGM leader with improving margins, $1B+ free cash flow and attractive risk-reward vs peers.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
